BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37246237)

  • 1. Dissecting the Interrelationship between COVID-19 and Diabetes Mellitus.
    Roham PH; Kamath JJ; Sharma S
    Adv Biol (Weinh); 2023 Aug; 7(8):e2300107. PubMed ID: 37246237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas.
    Müller JA; Groß R; Conzelmann C; Krüger J; Merle U; Steinhart J; Weil T; Koepke L; Bozzo CP; Read C; Fois G; Eiseler T; Gehrmann J; van Vuuren J; Wessbecher IM; Frick M; Costa IG; Breunig M; Grüner B; Peters L; Schuster M; Liebau S; Seufferlein T; Stenger S; Stenzinger A; MacDonald PE; Kirchhoff F; Sparrer KMJ; Walther P; Lickert H; Barth TFE; Wagner M; Münch J; Heller S; Kleger A
    Nat Metab; 2021 Feb; 3(2):149-165. PubMed ID: 33536639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
    Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
    Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited extent and consequences of pancreatic SARS-CoV-2 infection.
    van der Heide V; Jangra S; Cohen P; Rathnasinghe R; Aslam S; Aydillo T; Geanon D; Handler D; Kelley G; Lee B; Rahman A; Dawson T; Qi J; D'Souza D; Kim-Schulze S; Panzer JK; Caicedo A; Kusmartseva I; Posgai AL; Atkinson MA; Albrecht RA; García-Sastre A; Rosenberg BR; Schotsaert M; Homann D
    Cell Rep; 2022 Mar; 38(11):110508. PubMed ID: 35247306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients.
    Ji N; Zhang M; Ren L; Wang Y; Hu B; Xiang J; Gong Y; Wu C; Qu G; Ding W; Yin Z; Li S; Wang Z; Zhou L; Chen X; Ma Y; Tang J; Liu Y; Liu L; Huang M
    Emerg Microbes Infect; 2022 Dec; 11(1):1115-1125. PubMed ID: 35343389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells.
    Shaharuddin SH; Wang V; Santos RS; Gross A; Wang Y; Jawanda H; Zhang Y; Hasan W; Garcia G; Arumugaswami V; Sareen D
    Front Cell Infect Microbiol; 2021; 11():678482. PubMed ID: 34282405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus.
    Al-Kuraishy HM; Al-Gareeb AI; Alblihed M; Guerreiro SG; Cruz-Martins N; Batiha GE
    Front Cardiovasc Med; 2021; 8():644095. PubMed ID: 34124187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.
    Bhavya ; Pathak E; Mishra R
    J Endocrinol Invest; 2022 Mar; 45(3):537-550. PubMed ID: 34669152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE2 function in the pancreatic islet: Implications for relationship between SARS-CoV-2 and diabetes.
    Memon B; Abdelalim EM
    Acta Physiol (Oxf); 2021 Dec; 233(4):e13733. PubMed ID: 34561952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 and pancreas: a potential pathological interaction?
    Geravandi S; Mahmoudi-Aznaveh A; Azizi Z; Maedler K; Ardestani A
    Trends Endocrinol Metab; 2021 Nov; 32(11):842-845. PubMed ID: 34373155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection.
    Rasmi Y; di Bari I; Faisal S; Haque M; Aramwit P; da Silva A; Roshani Asl E
    Mol Biol Rep; 2024 Feb; 51(1):316. PubMed ID: 38376656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients' susceptibility to COVID-19 to the possible caution of future global diabetes tsunami.
    Sharbatdar Y; Mousavian R; Noorbakhsh Varnosfaderani SM; Aziziyan F; Liaghat M; Baziyar P; Yousefi Rad A; Tavakol C; Moeini AM; Nabi-Afjadi M; Zalpoor H; Kazemi-Lomedasht F
    Inflammopharmacology; 2023 Jun; 31(3):1029-1052. PubMed ID: 37079169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unwinding Link between Coronavirus and Diabetes Patient.
    Bhadauria SS; Malviya R; Sharma PK
    Endocr Metab Immune Disord Drug Targets; 2022; 22(11):1091-1110. PubMed ID: 35352656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes.
    Qadir MMF; Bhondeley M; Beatty W; Gaupp DD; Doyle-Meyers LA; Fischer T; Bandyopadhyay I; Blair RV; Bohm R; Rappaport J; Lazartigues E; Heide RSV; Kolls JK; Qin X; Mauvais-Jarvis F
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34241597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review.
    Magdy Beshbishy A; Oti VB; Hussein DE; Rehan IF; Adeyemi OS; Rivero-Perez N; Zaragoza-Bastida A; Shah MA; Abouelezz K; Hetta HF; Cruz-Martins N; Batiha GE
    Front Public Health; 2021; 9():591982. PubMed ID: 34307267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
    D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
    Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature.
    Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS
    Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19?
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Dubey R; Prabhakar PK; Batiha GE
    Curr Mol Pharmacol; 2023; 16(4):494-506. PubMed ID: 36089790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis.
    Kaminska H; Szarpak L; Kosior D; Wieczorek W; Szarpak A; Al-Jeabory M; Gawel W; Gasecka A; Jaguszewski MJ; Jarosz-Chobot P
    Acta Diabetol; 2021 Aug; 58(8):1101-1110. PubMed ID: 33778910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.